Clinical Evaluation of T-AYU-HM Premium in Sickle Cell Disease (HbSS) Patients: A Retrospective Study

ABSTRACT

Background:Sickle cell disease (HbSS) is one of the main hemoglobinopathies that affect the indigenous tribes and is a significant cause of morbidity and mortality. The effectiveness and safety of alternative medicines for sickle cell disease patients require further scientific study. The proposed study was conducted to clinically evaluate the safety and effectiveness of T-AYU-HM Premium Tablet (300 mg). Materials and Methods:This is a single-arm observational retrospective cohort study of 100 sickle cell disease subjects. Based on inclusion and exclusion criteria, the clinical and vital information of the patients was acquired, assessed, and reported. A follow-up period of 120±10 days was deemed sufficient. Data were analysed using a statistical package for the social sciences (SPSS). Results:The levels of haemoglobin (g/dL) (9.43±1.83 to 10.11±1.37) and red blood cells (/mm3) (3.89±0.81 to 4.18±0.64) were significantly improved (p<0.05). Reticulocyte count (%) changed significantly from 4.51±3.20 to 2.84±2.34. The number of blood transfusions (7.12±26.80 to 00) and the percentage of hospitalisations (76% to 00) that occurred more than six times prior to presentation were significantly reduced. Conclusion:In this retrospective analysis, there were no reported adverse consequences. Patient’s responses and all the clinical parameters like haematology, liver function parameters, clinical, and pain-associated symptoms with the disorder showed T-AYU-HM Premium to be an effective and safer therapy in the treatment of sickle cell anemia. Further well-planned interventional studies may become useful to justify the same.

KEYWORDS

• Sickle cell disease (HbSS)
• Haemoglobin
• Reticulocytes

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2024.16.38Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 16, ISSUE 2Enhanced Rhinacanthin Production in Rhinacanthus nasutus Roots Using a Hydroponics and Elicitation SystemThongtham Suksawat, Pharkphoom Panichayupakaranant · pp. 216–222Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 2Phytochemical Screening, Acute Toxicity and Evaluation of in vitro Antiurolithaitic Activity of Ethanolic and Methanolic Root and Leaf Extracts of Acalypha indica Linn.Anil Kumar, Ashish Kumar Sharma · pp. 223–228Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 2Novel Antibacterial Activity and Time Kill Kinetics of Ethanolic Extract of Ipomea marginata against Select Oral Micro-organisms Causing Gingivitis-An in vitro StudyVandana Sekizhar, Saravanakumar Ravindran, Saravanan Devarajan, Vijayan Venugopal, Raja Arun · pp. 229–235Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 2Study, Docking, in silico ADME and Predicted Acute Toxicity of Novel Hetero-Aromatic Imidazolidine Analogues as Potential Anti-Epileptic AgentsRohit Jaysing Bhor, Mayur Sitaram Gaikwad, Omprakash Arjunrao Londhe, Tanaya Prakash Wakchaure, Sambodhi Ashokrao Patil, Prashant Suresh Ingle, Pallavi Annasaheb Sonawane · pp. 236–243Original ArtcileSame type: Article